Skip to main content
. 2023 Nov 23;17(4):952–960. doi: 10.1007/s12105-023-01597-z

Fig. 2.

Fig. 2

A Representative staining of primary and recurrent tumors for CD3, CD8, and PDL1. B Distribution of immune infiltration and PDL1 positive cells across primary and recurrent tumors (scale bars represents 50µm)